Open this publication in new window or tab >>Anaesthesiology and Intensive Care, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; AdvanSci Research Solutions, Lund, Sweden.
Anesthesiology and Intensive Care, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden; Department of Intensive and Perioperative Care, Skåne University Hospital, Malmö, Sweden.
Anaesthesiology and Intensive Care, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Department of Intensive and Perioperative Care, Skåne University Hospital, Lund, Sweden.
Anaesthesiology and Intensive Care, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Department of Intensive and Perioperative Care, Skåne University Hospital, Lund, Sweden.
Department of Anaesthesiology and Intensive Care, Östersund Hospital, Östersund, Sweden.
Department of Operation and Intensive Care, Hallands Hospital Halmstad, Halmstad, Sweden.
Department of Operation and Intensive Care, Hallands Hospital Halmstad, Halmstad, Sweden.
Department of Anaesthesiology and Intensive Care Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Stockholm, Sweden.
Department of Clinical Science and Education, Section of Perioperative and Intensive Care, Karolinska Institute Södersjukhuset, Stockholm, Sweden.
Department of Diagnostics and Intervention, Umeå University and Umeå Centre for Microbial Research, Umeå University, Umeå, Sweden.
Department of Anaesthesiology and Intensive Care, Falun Hospital, Falun, Sweden; Anaesthesiology and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Department of Operation and Intensive Care, Hallands Hospital Varberg, Varberg, Sweden.
Örebro University, School of Medical Sciences. Örebro University Hospital. Department of Anaesthesia and Intensive Care.
Department of Anaesthesia and Intensive Care, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Department of Anaesthesia and Intensive Care, Norrtälje Hospital, Norrtälje, Sweden; Division of Pediatric Oncology, Department of Women and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Department of Anaesthesiology and Intensive Care Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Anaesthesia and Intensive Care, Södertälje Hospital, Södertälje, Sweden.
Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden; Department of Clinical Sciences, Karolinska Institutet, Stockholm, Sweden.
Department of Anaesthesiology and Intensive Care, Helsingborg Hospital, Helsingborg, Sweden; AdvanSci Research Solutions, Lund, Sweden.
Anesthesiology and Intensive Care, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.
Infectious Diseases, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Anaesthesiology and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Department of Anaesthesia and Intensive Care, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Adult Critical Care, University Hospital of Wales, Cardiff, UK.
Department of Anaesthesiology and Intensive Care, Helsingborg Hospital, Helsingborg, Sweden; Anaesthesiology and Intensive Care, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Copenhagen Trial Unit, Centre for Clinical Intervention Research, The Capital Region, Copenhagen University Hospital, Copenhagen, Denmark; Department of Regional Health Research, The Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
Show others...
2025 (English)In: Acta Anaesthesiologica Scandinavica, ISSN 0001-5172, E-ISSN 1399-6576, Vol. 69, no 7, article id e70095Article in journal (Refereed) Published
Abstract [en]
In septic shock, administration of large fluid volumes is associated with poor outcomes. Recent evidence shows that non-resuscitation fluids are the major modifiable source of fluids for patients with septic shock in intensive care units (ICUs). This clinical trial is designed to test the hypothesis that restrictive administration of non-resuscitation fluids improves outcomes compared to usual care. Adult patients admitted to ICUs with septic shock will be randomly assigned within 12 h of admission to receive protocolized restrictive administration of non-resuscitation fluids or usual care. The primary outcome is all-cause mortality at 90 days. Secondary outcomes are complications during ICU stay up to 90 days (defined as any acute kidney injury or cerebral, coronary, intestinal, or limb ischemia), mechanical ventilation free days within 90 days, and for survivors cognitive function (by the Montreal Cognitive Assessment [MOCA-BLIND]) and Health-Related Quality of Life (by the EQ Visual Analogue Scale [EQ-VAS]), both at 6 months. In addition, the climate impact of the interventions will be assessed. To detect an absolute reduction in mortality of 7.5%, with an alpha of 5% and a power of 90%, we aim to include 1850 patients. The trial is approved by the Swedish Ethical Review Authority. Results of primary and secondary clinical outcomes and the environmental outcome will be submitted for publication in a peer-reviewed journal.
Trial Registration: NCT06140147.
Place, publisher, year, edition, pages
John Wiley & Sons, 2025
National Category
Anesthesiology and Intensive Care
Identifiers
urn:nbn:se:oru:diva-122654 (URN)10.1111/aas.70095 (DOI)001535067500005 ()40671283 (PubMedID)2-s2.0-105011100273 (Scopus ID)
Funder
Swedish Research Council, 2023-00257Anna and Edwin Bergers FoundationStig och Ragna Gorthons stiftelseRegion Skåne
Note
This work was supported by the Swedish Research Counsil (2023-00257), the Anna och Edwin Bergers Foundation, the Stig and Ragna Gorthon Foundation, a Swedish government grant for clinical research within the Swedish National Health Service (ALF Grant number 86626) and a Regional Research Grant from Region Skåne, Sweden.
2025-08-122025-08-122026-01-23Bibliographically approved